Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

about

Total Bilirubin in Prognosis for Mortality in End-Stage Renal Disease Patients on Peritoneal Dialysis Therapy.HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.

P2860

Q47252885-D64ECDBC-CEFD-41FD-AED2-71D9A9044E2B Q55420511-53E487E8-F0B3-40BF-B1E5-8C2D4591EDAC

P2860

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

Item

http://www.wikidata.org/entity/Q48038746

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@en

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@nl

type

Item

label

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@en

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@nl

prefLabel

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@en

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@nl

P1476

Still a reasonable goal: Targe ...... ronic kidney disease patients.

@en

P2093

Gunnar H Heine

http://www.w3.org/2001/XMLSchema#string

Kyrill S Rogacev

http://www.w3.org/2001/XMLSchema#string

Oliver Weingärtner

http://www.w3.org/2001/XMLSchema#string

P2860

Controversial role of plant sterol esters in the management of hypercholesterolaemia

Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of its composition and biology

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.

Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients.

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

P304

390-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/SDI.12621

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gunther Marsche

P577

2017-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28628255

http://www.w3.org/2001/XMLSchema#string

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

about

P2860

P2860

Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698